+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

AI for Scientific Discovery - Global Strategic Business Report

  • PDF Icon

    Report

  • 181 Pages
  • June 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 6235948
The global market for AI for Scientific Discovery was estimated at US$3.7 Billion in 2025 and is projected to reach US$13.5 Billion by 2032, growing at a CAGR of 20.2% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Artificial Intelligence (AI) for Scientific Discovery Market - Key Trends & Drivers Summarized

How Is Artificial Intelligence Accelerating Breakthroughs Across Scientific Disciplines?

Artificial Intelligence for scientific discovery is reshaping research methodologies by enabling data intensive experimentation, simulation, and hypothesis generation across multiple disciplines. From molecular biology and materials science to astrophysics and climate modeling, AI systems are being deployed to analyze complex datasets that exceed the processing capacity of conventional analytical tools. Machine learning algorithms identify hidden correlations within genomic sequences, chemical compounds, astronomical observations, and environmental datasets. In pharmaceutical research, AI models are screening millions of molecular structures to predict drug candidate viability, toxicity profiles, and protein interactions. In physics and materials engineering, deep learning models assist in discovering novel materials with optimized conductivity, strength, or thermal properties. Climate scientists use AI driven simulations to model long term environmental scenarios based on multivariate datasets. The integration of AI with laboratory automation systems is enabling autonomous experimentation platforms capable of iteratively refining research parameters. Large scale scientific collaborations are leveraging cloud based AI infrastructure to share models and datasets across international research networks. Natural language processing systems are mining academic literature to identify emerging research patterns and potential knowledge gaps. As experimental data generation accelerates through advanced sensors and high throughput equipment, AI is becoming essential for transforming raw information into actionable scientific insights.

Why Are Research Institutions Integrating AI Into Experimental and Analytical Workflows?

Research institutions are integrating AI into experimental design and analytical workflows to address increasing complexity and scale within scientific investigations. Modern research projects generate vast amounts of structured and unstructured data from imaging systems, particle accelerators, genome sequencers, and environmental monitoring networks. AI driven analytics platforms enable rapid interpretation of these datasets, reducing the time between hypothesis formulation and validation. Predictive modeling tools assist researchers in narrowing experimental variables, optimizing resource allocation within laboratories. In biomedical research, AI systems are analyzing patient data to identify biomarkers associated with disease progression. In chemistry and materials science, generative models propose new molecular structures that meet predefined performance criteria. Universities and national laboratories are incorporating AI training into research curricula to prepare scientists for computationally enhanced methodologies. Collaborative research ecosystems are deploying shared AI platforms to accelerate cross disciplinary knowledge exchange. Funding agencies are increasingly prioritizing projects that integrate AI driven methodologies due to their potential to enhance research productivity. AI assisted literature review tools are streamlining discovery of relevant prior studies, enabling more informed experimental planning. As competition for scientific breakthroughs intensifies globally, institutions view AI integration as a strategic advantage in accelerating innovation cycles.

What Technological Innovations Are Expanding AI Capabilities in Scientific Research?

Technological advancements are significantly expanding the capabilities of AI systems in scientific discovery contexts. High performance computing clusters equipped with AI optimized accelerators are enabling large scale simulations of molecular dynamics and astrophysical phenomena. Reinforcement learning frameworks are guiding automated laboratory instruments to adjust experimental parameters dynamically. Federated learning architectures allow collaboration across institutions without transferring sensitive datasets. Advanced data visualization tools powered by AI are helping researchers interpret multidimensional data landscapes. Integration of quantum computing research with machine learning is opening pathways for solving previously intractable optimization problems. Digital twin technologies are being combined with AI models to simulate complex systems such as energy grids, biological organisms, and urban infrastructure. Edge computing applications are supporting real time data analysis within remote research environments such as oceanographic expeditions and space missions. Automated anomaly detection algorithms are identifying rare patterns within particle physics experiments and astronomical surveys. Cloud based research platforms are providing scalable infrastructure for collaborative model development. Continuous model retraining using updated experimental data is improving predictive accuracy over time. These technological innovations are collectively enhancing the precision, scalability, and interdisciplinary reach of AI enabled scientific research.

Which Market Drivers Are Fueling Global Expansion of AI for Scientific Discovery?

The growth in the Artificial Intelligence (AI) for Scientific Discovery market is driven by several factors including escalating global investment in research and development across pharmaceuticals, biotechnology, energy, and advanced materials sectors. The increasing volume and complexity of scientific datasets generated by modern instrumentation are creating demand for advanced analytical tools. Government funding initiatives aimed at accelerating innovation in healthcare, climate resilience, and sustainable energy are supporting AI integration within research programs. Growing collaboration between academia and industry is stimulating adoption of AI platforms for translational research applications. Rising demand for precision medicine and personalized treatment strategies is intensifying reliance on AI driven genomic and clinical data analysis. Expansion of space exploration missions and astronomical surveys is generating high resolution data requiring machine learning based interpretation. The proliferation of open access scientific databases is enabling broader training of AI models across disciplines. Increasing computational power availability through cloud infrastructure is lowering barriers to entry for research institutions adopting AI technologies. Competitive pressure among nations to achieve technological leadership in critical sectors is encouraging strategic investment in AI enabled research ecosystems. Additionally, integration of automated laboratory robotics with AI driven experimental design is enhancing research throughput and reproducibility. Collectively, these funding trends, technological advancements, interdisciplinary collaborations, and global innovation imperatives are propelling sustained growth of the Artificial Intelligence (AI) for Scientific Discovery market.

Report Scope

The report analyzes the AI for Scientific Discovery market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Technology (Generative Models Technology, Graph & Molecular Machine Learning Technology, Physics-Informed Machine Learning Technology, Simulation & Digital Twins Technology); Application (Target Discovery Application, De Novo Molecule Design Application, Biomarker & Omics Analysis Application, Predictive Toxicology Application); End-Use (Pharmaceutical Research & Development End-Use, Biotechnology Companies End-Use, Academic & National Labs End-Use, Chemical & Materials Science Firms End-Use)
  • Geographic Regions/Countries: World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Generative Models Technology segment, which is expected to reach US$4.3 Billion by 2032 with a CAGR of a 18.2%. The Graph & Molecular Machine Learning Technology segment is also set to grow at 22.1% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $1.1 Billion in 2025, and China, forecasted to grow at an impressive 19.4% CAGR to reach $2.3 Billion by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global AI for Scientific Discovery Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global AI for Scientific Discovery Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global AI for Scientific Discovery Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as AbCellera Biologics, Inc., Amazon Web Services, Inc., Benchling, BenchSci, BenevolentAI and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this AI for Scientific Discovery market report include:

  • AbCellera Biologics, Inc.
  • Amazon Web Services, Inc.
  • Benchling
  • BenchSci
  • BenevolentAI
  • Evaxion Biotech
  • Generate Biomedicines
  • Google, LLC
  • Healx Ltd.
  • IBM Corporation

Domain Expert Insights

This market report incorporates insights from domain experts across enterprise, industry, academia, and government sectors. These insights are consolidated from multilingual multimedia sources, including text, voice, and image-based content, to provide comprehensive market intelligence and strategic perspectives. As part of this research study, the publisher tracks and analyzes insights from 43 domain experts. Clients may request access to the network of experts monitored for this report, along with the online expert insights tracker.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • World Market Trajectories
  • How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind
  • Artificial Intelligence (AI) for Scientific Discovery - Global Key Competitors Percentage Market Share in 2026 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2026 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Exponential Growth in Research Data Volumes Propels Demand for AI Driven Scientific Discovery Platforms
  • Complexity of Multidisciplinary Research Strengthens the Business Case for AI Assisted Hypothesis Generation
  • Acceleration of Drug Discovery and Materials Science Expands Addressable Market Opportunities for AI Simulation Tools
  • Integration of AI With High Performance Computing Infrastructure Drives Advanced Modeling and Predictive Analytics
  • Funding Agency Focus on Translational Research Spurs Adoption of AI Enabled Experiment Optimization
  • Automation of Laboratory Workflows Generates Demand for AI Powered Robotic and Data Integration Systems
  • Genomics, Proteomics, and Omics Data Explosion Throws the Spotlight On Scalable AI Analytical Frameworks
  • Climate Modeling and Sustainability Research Initiatives Propel Investment in AI Driven Environmental Simulations
  • Reproducibility and Data Transparency Requirements Drive Procurement of Standardized AI Research Platforms
  • Advancements in Foundation Models for Science Sustain Innovation in Knowledge Extraction and Pattern Discovery
  • Digital Twin and Simulation Technologies Open New Pathways for Predictive Experimentation
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World AI for Scientific Discovery Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for AI for Scientific Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 3: World 8-Year Perspective for AI for Scientific Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2026 & 2032
  • Table 4: World Recent Past, Current & Future Analysis for Generative Models Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 5: World 8-Year Perspective for Generative Models Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 6: World Recent Past, Current & Future Analysis for Graph & Molecular Machine Learning Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 7: World 8-Year Perspective for Graph & Molecular Machine Learning Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Physics-Informed Machine Learning Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 9: World 8-Year Perspective for Physics-Informed Machine Learning Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 10: World Recent Past, Current & Future Analysis for Simulation & Digital Twins Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 11: World 8-Year Perspective for Simulation & Digital Twins Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 12: World Recent Past, Current & Future Analysis for Biotechnology Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 13: World 8-Year Perspective for Biotechnology Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Academic & National Labs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 15: World 8-Year Perspective for Academic & National Labs End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 16: World Recent Past, Current & Future Analysis for Chemical & Materials Science Firms End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 17: World 8-Year Perspective for Chemical & Materials Science Firms End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 18: World Recent Past, Current & Future Analysis for Pharmaceutical Research & Development End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 19: World 8-Year Perspective for Pharmaceutical Research & Development End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 20: World Recent Past, Current & Future Analysis for Target Discovery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 21: World 8-Year Perspective for Target Discovery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 22: World Recent Past, Current & Future Analysis for De Novo Molecule Design Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 23: World 8-Year Perspective for De Novo Molecule Design Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 24: World Recent Past, Current & Future Analysis for Biomarker & Omics Analysis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 25: World 8-Year Perspective for Biomarker & Omics Analysis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
  • Table 26: World Recent Past, Current & Future Analysis for Predictive Toxicology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 27: World 8-Year Perspective for Predictive Toxicology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • AI for Scientific Discovery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
CANADA
JAPAN
  • AI for Scientific Discovery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
CHINA
  • AI for Scientific Discovery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
EUROPE
  • AI for Scientific Discovery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
FRANCE
  • AI for Scientific Discovery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
GERMANY
  • AI for Scientific Discovery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
ITALY
UNITED KINGDOM
  • AI for Scientific Discovery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
REST OF EUROPE
ASIA-PACIFIC
  • AI for Scientific Discovery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
REST OF WORLD
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbCellera Biologics, Inc.
  • Amazon Web Services, Inc.
  • Benchling
  • BenchSci
  • BenevolentAI
  • Evaxion Biotech
  • Generate Biomedicines
  • Google, LLC
  • Healx Ltd.
  • IBM Corporation

Table Information